|
|
||||||||
CLINICAL STUDIES |
Pediatric Endocrinology Department, Centre de Référence des Maladies Endocriniennes Rares de la Croissance and Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 690, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Robert Debré Hospital, 75019 Paris, France
1 Regional Institute for Health, Tours, France
2 Unit of Clinical Epidemiology INSERM CIE5
3 Biochemistry Department, Assistance Publique-Hôpitaux de Paris, Université Paris VII, Robert Debré Hospital, 75019 Paris, France
(Correspondence should be addressed to J Léger Email: juliane.leger{at}rdb.aphp.fr)
Context: There is evidence to suggest that IGF-I plays a role in regulating bone turnover.
Objective: To evaluate the relationships between serum concentrations of IGF-I and IGF-binding protein-3 (IGFBP-3), and bone metabolism markers in healthy children.
Design and setting: Prospective cross-sectional study.
Subjects and methods: A cohort of 579 boys and 540 girls, all healthy Caucasian, were included in this study. Serum IGF-I and IGFBP-3 concentrations, bone alkaline phosphatase (BAP) and CrossLaps (markers of bone formation and bone resorption respectively) levels were evaluated as a function of age, gender, pubertal stage and body mass index.
Results: Serum IGF-I SDS levels were positively correlated with BAP and CrossLaps SDS levels before and after puberty, and also with CrossLaps during puberty (weak correlation). Serum IGFBP-3 SDS levels were positively correlated with BAP and CrossLaps levels before, during (weak correlation) and after puberty (for BAP levels only).
Conclusions: This study demonstrated the independent association between serum IGF-I and IGFBP-3 concentrations with both serum bone formation and resorption markers in healthy children. Physiological differences before, during and after puberty in the association of serum IGF-I and IGFBP-3 levels with the serum bone metabolism markers were found. These differences may be related to differences in interactions between sex steroid hormones and the GH/IGF-I system, bone metabolism and growth during the pubertal transition. Improvements in our understanding of life course determinants of the IGF-I system and bone metabolism are required to shed further light on the role of the GH/IGF-I axis in bone remodelling.
This article has been cited by other articles:
![]() |
R. I. Aqeilan, M. Q. Hassan, A. de Bruin, J. P. Hagan, S. Volinia, T. Palumbo, S. Hussain, S.-H. Lee, T. Gaur, G. S. Stein, et al. The WWOX Tumor Suppressor Is Essential for Postnatal Survival and Normal Bone Metabolism J. Biol. Chem., August 1, 2008; 283(31): 21629 - 21639. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |